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Editorial
Hong Kong Cardiology During the Severe Acute Respiratory
Syndrome (SARS) Outbreak
CHU-PAK LAU1 AND PATRICK T H KO2
1

Editor-in-Chief, Journal of Hong Kong College of Cardiology; 2Immediate Past President, The Hong Kong College
of Cardiology

The first case of Severe Acute Respiratory
Syndrome (SARS) broke out at the end of February 2003
in Hong Kong, and had since made significant impact
on all walks of life in Hong Kong, including the medical
profession. The Cardiology community and practicing
cardiologists were affected in different ways during this
period.
Right at the time and before anybody knew about
SARS, the World Congress on Cardiac Pacing and
Electrophysiology were being held between February
19-22, 2003. In retrospect, the organizer, the Hong Kong
College of Cardiology, was very fortunate to have
successfully hosted the meeting, with over 4,000
participants from 20 countries attending.1 If SARS had
occurred earlier, the attendance would have been dismal,
and most probably the entire congress would have to
be cancelled. With divine blessing perhaps, all the
faculty and attendees had enjoyed their visit and
returned home safely.
During the outbreak, there was severe manpower
and bed shortage for SARS patients. As a result, routine
cardiac activities almost came to a standstill. Many
patients cancelled their appointments for fear of
contacting SARS, and the numbers of outpatient
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attendance and cardiac procedures were dramatically
reduced. In some hospitals, catheterization laboratory
had to be closed e.g. Princess Margaret Hospital. In other
hospitals, e.g. Queen Mary Hospital, one of the two
cardiac catheterization laboratories was closed during
this period. A similar situation also occurred in the
private sector. For the usually overworked cardiologist,
this seemed to be a good time for respite. However, in
reality, we felt very frustrated from this inactivity, and
we were not alone.
Many cardiologists in the Hospital Authority took
active role in the management of SARS patients.
Because of their experience in critical care, some of
them worked in high risk areas delivering medical care
directly to those in need. They had made important
contributions to the medical community. In the early
outbreak of SARS, a number of cardiologists had
contracted SARS and, some became very sick. We are
now thankful that they have all survived, and most have
already returned to full clinical duties.
SARS has provided opportunity for those
academically inclined. A group of cardiologists in Hong
Kong has just published the first landmark study on the
effects of SARS virus on cardiac function. Li et al2
reported subclinical diastolic dysfunction in 46 patients
with SARS, 14 of them were ventilator dependent
patients. While there was no systolic dysfunction
observed in these cases as a group, ventilated patients
tended to have lower ejection fraction which was related
to the serum level of lactase dehydrogenese. Left
ventricular function recovered among the survivors.
Many meetings were cancelled or postponed. The
11th Annual Scientific Session of the Hong Kong
College of Cardiology, scheduled in June 2003, was
initially postponed to August, and finally to October
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31-November 2, 2003. The organizing committee has
made tremendous effort in liaising with the faculty and
the industry to put together a meeting of very high
standard. It will be one of the largest medical meetings
after the SARS outbreak.
In summary, cardiologists in Hong Kong have
suffered, made significant contributions and maintained
their duties to their patients during the SARS outbreak.
The hosting of the 11th Annual Scientific Meeting is a
testimony of their commitment. This editorial in written
as a tribute to all cardiologists who have served the
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people of Hong Kong selflessly during the difficult
SARS period.
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Letter to the Editor
An Open Letter to The Hong Kong College of Cardiology Regarding
Electron Beam Computed Tomography (EBT)

Dear Editor,
Ref: "Comment on Electron Beam Computed
Tomography" by Dr. Patrick T H Ko. Letter to the
Editor, J HK Coll Cardiol, Vol 11, 2003.
My experience with Electron Beam Computed
Tomography (EBT) now dates me at over 20 years of
research and clinical practice, initially in cardiac
physiology, but for the past decade in coronary
atherosclerosis, athersoclerosis imaging, and Preventive
Cardiology. Thus, I feel I can speak from some level of
authority as well as considerable experience. The point
in question relates to the use of EBT and coronary
calcium scoring for defining coronary disease in a noninvasive manner. I will admit, like many trained formally
in traditional Cardiology and brought up with the idea
that definition of coronary stenoses severity was our
standard in defining coronary disease, that my initial
efforts in using coronary calcium were directed towards
that end.
Our initial studies from autopsy specimens during
my tenure at the Mayo Clinic defined that coronary
calcium area, by direct histologic comparisons as well
as by EBT, was a valid surrogate to defining in situ
atherosclerotic plaque.1-3 The next step was to then
determine application of the non-invasive EBT calcium
score to defining stenosis severity in patients referred
for clinically indicated invasive coronary angiography.
This is where our initial efforts demonstrated that we
could in fact NOT define coronary stenosis severity
adequate for clinical diagnostic purposes using the EBT
calcium score.4,5 I was initially taken-aback by these
findings and also joined with my cardiology colleagues
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in defining the potential for "false positive" results using
EBT. In fact, however, as I have come to learn, the
results were NOT false, but clearly showed that
coronary calcium in any given site is 100% specific
for coronary atherosclerosis, but NOT specific for
the degree of narrowing. My Mayo Clinic colleagues
and I in fact further investigated this and reported on a
resolution of the problem in a separate necropsy study.6
What we found was that coronary calcium did continue
to define coronary atheromatous plaque, but failed to
define site-by-site stenosis severity due to the
phenomenon of coronary artery remodeling, mentioned
by Dr. Ko in his Editorial. This concept was initially
reported by Dr. Glagov, at the University of Chicago,
where he and his colleagues demonstrated that coronary
plaque may progress by expanding the mural surfaces
and yet not necessarily, until its later stages, result in
luminal narrowing.7
The traditional view from most Cardiologists had
been that a definition of "coronary artery disease" was
a stenosis of significant magnitude, defined as generally
representing a singular or multiple narrowing defined on
a "luminogram" of >50-70%. Over the years, however,
we have subsequently learned that atherosclerosis is
a diffuse disease and that focusing, as a means of
defining "disease", on a stenosis of >50% vastly
underestimates the severity and extent of the
underlying atherosclerosis in a given individual.
Dr. Steven Nissen, Vice-Chair of Cardiology at the
Cleveland Clinic, has perhaps been the best at pointing
out the inadequacies of traditional coronary angiography
by performing simultaneous investigations using
intravascular ultrasound (IVUS). He has demonstrated
that individuals may well have a "normal" coronary
angiogram (i.e. luminogram) and yet have "significant"
atheromatous disease 8 due to "positive coronary
remodeling". Subsequent to these investigations my
colleagues and I compared "apples with apples"
demonstrating that the coronary artery calcium score
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by EBT correlated well with IVUS definition of
atheromatous plaque.9,10
Dr. Ko states in his Editorial that coronary
angiography is "…the diagnostic gold standard…".
Many recent authors would dispute that statement as it
relates to atheromatous plaque, as discussed above,
although it does remain the clinical standard for defining
the site of "significant luminal narrowing" that are targets
for PCI and/or road maps for bypass surgery. His
statement later however that "EBCT (is)…not
specific or accurate in so far as the diagnosis or the
staging of clinically significant coronary disease…"
is frankly and explicitly inaccurate. The goal of EBT
is to define the extent of atherosclerotic plaque and thus
its "accuracy" in defining clinically significant disease
should be better understood in its ability to predict risk
of coronary events or clinically significant outcomes. The
premise (or promise, more appropriately) of EBT is not
to "define significant coronary artery disease", as
implied by Dr. Ko, but to define the extent of coronary
artheromatous plaque. Thus he has mis-stated his claim
when he indicated that "The premise of EBCT is thus
defeated". In fact the "promise" of EBT has been
fortified by collective literature that has added
incrementally to our understanding over the past decade.
Dr. Ko is indeed correct in that the formation of
mural coronary artery calcification, in response to the
inflammatory nature of coronary disease, may well form
to provide a lattice of support in an attempt to render
the plaque stable. However, the pathological literature
shows11 that 80% of the "culprit" lesions in necropsy
studies contain histologic calcium hydroxyapatitie.
However, many stable lesions show the same predilection
underscoring that coronary calcium is neither a unique
marker for stable nor unstable plaque. Although so called
"vulnerable" plaques have been shown to be more
predominantly lipid laden than calcium laden, this does
not limit the value of EBT and calcium scoring in
estimating the overall extent of atherosclerosis plaque
present. In any given individual about 2/3 of plaque is in
fact "scar" and about 1/3 is more predominantly "lipid
laden". Thus EBT cannot be used to define which plaque
is unstable, but can and has been shown to define disease
extent (even compared with the "extent" of angiographic
disease or the extent of thallium perfusion defects12).
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The proof of the above statements must be
founded in the prediction of clinical outcomes using
coronary calcium by EBT as a measure of disease.
Although Dr. Ko quotes one paper suggesting that EBT
provided no incremental value over the sum of ALL
conventional risk factors 13 [of note and lost to most
"crities" is that risk factors also failed to predict events
adequately in the same cohort], subsequent research
(even from that same laboratory) has demonstrated
that the coronary calcium score by EBT provided
prognostic information independent and
incremental to conventional risk factors. 14-17
Angiographic studies over the past 25 years have
demonstrated that the extent of coronary disease is
directly related to prognosis. 18,19 The presence of
moderate amounts of coronary calcium (i.e., EBT scores
exceeding 100) has been shown in several studies to
predict cardiac events in symptomatic 20 and
asymptomatic21 individuals. The relative risk of a cardiac
event in an individual with a moderate to high calcium
score by EBT compared to an individual who has no or
minimal coronary calcium has ranged form a mean of
8.66:122 in a meta-analysis review of EBT to as high as
15:123 over a 2-4 year follow up time period in a more
recent publication. The magnitude of the risk associated
with coronary calcium is underscored when one
considers the relative risks of developing symptomatic
coronary artery disease in younger patients based upon
conventional individual "risk factors" (15 year follow up
Framingham study of initially asymptomatic men) is only
1.9:1 for an elevated Lp(a), 1.8:1 for total cholesterol
>240 mg/dl., 1.8:1 for an HDL <35 mg/dl, 3.6:1 for
cigarette smoking, and 1.2:1 for systolic hypertension.24
The data show that, although EBT cannot define
coronary stenosis severity, it CAN suggest that with
higher scores, or in the presence of symptoms24 that
further examination such as stress testing, EBA
(electron beam non-invasive coronary angiography), or
even formal angiography may be warranted. However,
this determination must be made on a case-by-case basis
and is a clinical decision made by an experienced
practitioner. Outcomes of such subsequent testing are
then used to assist in the patient's care.
The current overall guidelines for EBT test
interpretation can be expressed in several bullet points
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as provided below. These statements, supported by
published literature, still must function only as overall
"guides" for the clinician. However, in my opinion, these
interpretation are in fact being well put forward by
experienced practitioners currently performing EBT
examinations in Hong Kong.
Interpretation and recommendation for EBT heart
scanning and CAC scoring:
• A negative test (i.e. score=0, no detectable coronary
calcium) makes the presence of atherosclerotic
plaque, including unstable or vulnerable plaque, highly
unlikely.
• A negative test (score=0) makes the presence of
significant luminal obstructive disease highly unlikely
(negative predictive power by EBT on the order of
95-99%).
• A negative test is consistent with a low risk (reported
to be <0.5% per year26) of a significant cardiovascular
event [infarction or sudden death] in the next 2-5
years.
• A positive test (i.e. a score >0) confirms the presence
of a coronary atherosclerotic plaque (100%
specificity for fibro-atheromatous plaque).
• The greater the EBT calcium score, the greater the
atherosclerotic burden in men and women,
irrespective of age, and the greater "likelihood" of
more advanced luminal disease.5
• The total (summed) coronary calcium score
correlated best with the total amount of coronary
atherosclerotic plaque, although the true
"atherosclerotic burden" is underestimated and,
without use of contrast (as in an EBA study), "soft"
plaque may not be well appreciated (but data are
advancing to address this issue using non-contrast
EBT 27).
• A high calcium score (an Agatston score >100 or
any score above the 75th percentile for age and sex
as compared to published EBT databases) is
consistent with a moderate to high risk of a cardiac
event within the next 2-5 years.
• Coronary artery calcium measurement can improve
risk prediction in conventional intermediate-risk
patients and such scanning should be considered in
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individuals at intermediate risk for a coronary event
(0.6%/year to 2.0%/year) for clinical-decision making
regarding refinement of risk stratification28 (recent
data suggest that in low to intermediate risk patients
the current goals of applying only conventional risk
stratification may not be adequate in defining true
risk for myocardial infarction, at least in individuals
at an average age of 50 years29).
• High coronary calcium scores (an Agatston score
>100 or any score above the 75th percentile for age
and sex) denotes advanced coronary atherosclerosis
and provides a rationale for intensified LDL-c
lowering therapy and assignment of coronary risk to
a "coronary disease risk-equivalency" status (i.e.
secondary prevention goals such as a target LDL-c
range <100 mg/dl).
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Letter to the Editor
CT Scanning the Coronaries for Calcium – Why the Controversy?
Dear Editor,
Few recent topics in cardiovascular medicine have
engendered as much debate as the now vexed issue of
high resolution CT scanning of the coronary arteries for
calcium, as a predictor of coronary disease risk. As
presymptomatic detection of atherosclerosis is a vital
and still unsolved problem in clinical practice, open
discussion about this topic is very important. It is equally
important, however, that clinical practitioners have a
clear idea of the 'state of the art', in order to help guide
management of individual patients.
The essential facts concerning coronary calcium
scanning are not in dispute. Non-invasive tests to assist
in risk stratification are clearly needed, for low and
intermediate-risk patients. CT scanning can detect
calcium in the coronary arteries and this is clearly a
marker of the burden of atherosclerosis in the coronary
circulation. If the coronary calcium score is '0',
subsequent risk of events in the medium turn is very low
(although not zero) and if the calcium score is high, this
clearly indicates not only the presence of extensive
atherosclerotic plaque, but also improved risk prediction,
compared with conventional risk factor assessment
only. 1 Nevertheless, despite excellent sensitivity for
disease, CT scanning for coronary calcium has much
less good specificity, resulting in a high number of 'false
positive' tests (in terms of predicting actual events). This
may cause undue concern in asymptomatic subjects and
can lead to a series of subsequent cardiac diagnostic
tests, which may have low yield. It is also not in dispute
that this is an area worthy of further investigation, and
accordingly data are accumulating rapidly about the role
of this test in clinical practice.
Against this very promising background
information, the experience in many countries, including

Opinions expressed are views of the authors and not necessarily
the view of the editorial board or the Hong Kong College of
Cardiology.
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Australia as well as Hong Kong, has been that the test
has been introduced to the public with occasionally with
aggressive marketing and advertising strategies, directed
at the general community. This has sometimes occurred
before the medical profession has accepted the benefits
of coronary CT scanning. Publicity such as 'the most
important advertisement you'll ever read' (or phrases
similar) has appeared in high circulation newspapers and
journals. Not surprisingly, the uptake rate by a public
well educated and concerned about the dangers of heart
disease has been high. Some subjects have been very
relieved by early detection of a high calcium score and
subsequent workup, others have been relieved by a
reassuringly negative calcium score, but many have been
worried by the news that they have 'coronary calcium',
without a clear diagnostic or therapeutic pathway for
them or their doctors to follow. Marketing direct to the
public along these lines is contrary to the more traditional
medical model with which doctors are comfortable,
wherein evidence is carefully evaluated, learned societies
and/or key opinion leaders come to a consensus, and
then information is disseminated to the public through
specialists, GPs and medically-based education.
Herein lies the genesis of some of the controversy
surrounding coronary CT scanning. Those specialists
involved in centres which have 'marketed' coronary CT
scanning have been cast by some as 'irresponsible
entrepreneurs' preying on the latent fears of a gullible
public, whereas members of the profession who have
adopted a more conservative stance can be cast as
latter-day Luddites, delaying the uptake of promising new
technologies which may have real health benefits, to the
detriment of the general community. Such tensions often
accompany the introduction of novel and exciting
technologies, but can be particularly acute when
significant sums of money can be made or lost, on the
acceptance or otherwise of expensive new techniques.
A series of excellent review articles and letters
have appeared in the Journal this year, commenting with
different degrees of enthusiasm on the burgeoning use
of electron beam CT for the non-invasive assessment

October 2003

J HK Coll Cardiol, Vol 11

CELERMAJER

of coronary artery calcium and its role in predicting
coronary risk.2-4 These are all sensible and well-balanced
viewpoints from highly regarded experts in the practice
of cardiovascular medicine.
How then, to find perspective on this issue?
This is an exciting area of research, about which we
will all read more in the coming years. At the time of
writing, the American College of Cardiology and the
American Heart Association have produced
consensus documents on electron beam CT for the
diagnosis and prognosis of coronary artery disease,
suggesting that this technique not be employed for
non-invasive screening of asymptomatic subjects at
risk of cardiovascular events.5 Newer data have since
been published, however, 1 which may in time result
in the revision of these recommendations, especially
if similar results can be obtained in other supportive
studies. As a community, we need to keep an open
mind about such new data, whilst vigorously protecting
our patients from unproven diagnostic and/or
therapeutic strategies.
Some other questions need to be answered about
coronary CT scanning. Firstly, cost/benefit analyses will
be important in a cost-conscious era where other
putative markers of coronary risk (such as high sensitivity
CRP assays and ultrasound measurement of arterial wall
thickness) may be considerably cheaper than CT
scanning, and not carry any radiation risk. Secondly, are
non-electron beam CT scanners as reliable, in the
detection of calcium? Most importantly of all,
cardiologists will want to have practical guidance on
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which calcium scores in which patients should prompt
which further diagnostic tests and/or treatment options.
This is an important topic, and the Journal is to be
congratulated for publishing high quality articles,
commentaries and letters on this subject. In the next 5
years, we will almost certainly find out whether coronary
CT scanning for calcium is 'hype' or 'hope'. In the interim,
a search for the right test for presymptomatic
determination of coronary risk remains a 'Holy Grail' of
internal medicine, as the worldwide prevalence of
atherosclerotic disease continues its inexorable climb.
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